Qube Research & Technologies LTD Innoviva, Inc. Transaction History

Qube Research & Technologies LTD

$91.4 Billion
Q3 2025

A detailed history of Qube Research & Technologies LTD transactions in Innoviva, Inc. stock. As of the latest transaction made, Qube Research & Technologies LTD holds 1,023,534 shares of INVA stock, worth $22.8 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

1,023,534

Previous 608,645 68.17%

Holding current value

$22.8 Million

Previous $12.2 Million 52.77%

% of portfolio

0.02%

Previous 0.01%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	BUY	$18.17 - $20.92 $7.54 Million - $8.68 Million	414,889 Added 68.17%	1,023,534 $18.7 Million
Q2 2025 Aug 14, 2025	SELL	$17.1 - $21.8 $6.31 Million - $8.04 Million	-368,715 Reduced 37.73%	608,645 $12.2 Million
Q1 2025 May 15, 2025	BUY	$17.21 - $18.98 $8.39 Million - $9.25 Million	487,523 Added 99.53%	977,360 $17.7 Million
Q4 2024 Feb 14, 2025	BUY	$17.35 - $20.32 $8.3 Million - $9.72 Million	478,511 Added 4224.89%	489,837 $8.5 Million
Q3 2024 Nov 14, 2024	SELL	$16.33 - $20.04 $107,369 - $131,763	-6,575 Reduced 36.73%	11,326 $218,000

Q2 2024 Aug 14, 2024	SELL	$14.4 - $16.4 $391,464 - $445,833	-27,185 Reduced 60.3%	17,901 $293,000
Q1 2024 May 14, 2024	BUY	$14.56 - $16.78 $656,452 - $756,543	45,086 New	45,086 $687,000
Q3 2022 Nov 14, 2022	SELL	$11.61 - $15.22 $213,438 - $279,804	-18,384 Reduced 12.63%	127,203 $1.48 Million
Q2 2022 Aug 15, 2022	BUY	$14.32 - $19.88 $1.35 Million - $1.87 Million	94,155 Added 183.07%	145,587 $2.15 Million
Q1 2022 May 09, 2022	BUY	$15.39 - $20.25 $67,654 - $89,019	4,396 Added 9.35%	51,432 $995,000
Q4 2021 Feb 01, 2022	BUY	$15.91 - $18.72 $748,342 - $880,513	47,036 New	47,036 $811,000
Q2 2021 Aug 13, 2021	SELL	$11.45 - $13.96 $273,609 - $333,588	-23,896 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$11.06 - $12.87 $264,289 - $307,541	23,896 New	23,896 $286,000
Q4 2020 Feb 16, 2021	SELL	$9.33 - $12.48 $308,692 - $412,913	-33,086 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$10.33 - $14.49 $341,778 - $479,416	33,086 New	33,086 $346,000
Q2 2020 Aug 14, 2020	SELL	$11.49 - $15.26 $217,965 - $289,482	-18,970 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$8.11 - $15.23 $153,846 - $288,913	18,970 New	18,970 $223,000

Others Institutions Holding INVA

# of Institutions

281

Shares Held

82.7M

Call Options Held

13.2K

Put Options Held

156K

View Full List

About Innoviva, Inc.

Ticker INVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,706,000
Market Cap $1.55B
Description
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...

More about INVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.

Account

Qube Research & Technologies LTD Innoviva, Inc. Transaction History